| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| cefadroxil (som cefadroxilmonohydrat) 50 milligram/milliliter, oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| cefadroxil (som cefadroxilmonohydrat) 50 milligram/milliliter, oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely flucloxacillin (as flucloxacillin sodium) 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely flucloxacillin (as flucloxacillin sodium) 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Clomethiazole (as clomethiazole edisilate) 50 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Clomethiazole (as clomethiazole edisilate) 50 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Ibuprofen 20 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Ibuprofen 20 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely chloroquine phosphate 16 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely chloroquine phosphate 16 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Primidone 50 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Primidone 50 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely chloroquine sulfate 13.6 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely chloroquine sulfate 13.6 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| cefadroxil (som cefadroxilmonohydrat) 100 milligram/milliliter, oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| cefadroxil (som cefadroxilmonohydrat) 100 milligram/milliliter, oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely ephedrine hydrochloride 800 microgram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely ephedrine hydrochloride 800 microgram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| nevirapin (som nevirapinhemihydrat) 10 milligram/milliliter, oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| nevirapin (som nevirapinhemihydrat) 10 milligram/milliliter, oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Folic acid 80 microgram/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Folic acid 80 microgram/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Codeine phosphate 5 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Codeine phosphate 5 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| Furosemide 4 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Furosemide 4 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely nabumetone 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely furosemide 8 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely furosemide 8 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely cefixime 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely cefixime 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Alpha tocopheryl acetate 100 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Alpha tocopheryl acetate 100 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Dihydrocodeine tartrate 2 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Dihydrocodeine tartrate 2 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Diazepam 400 microgram/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Diazepam 400 microgram/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely furosemide 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Chlorpromazine hydrochloride (as chlorpromazine embonate) 20 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Chlorpromazine hydrochloride (as chlorpromazine embonate) 20 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Prednisolone 3 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Inositol nicotinate 200 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Inositol nicotinate 200 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin (as erythromycin ethylsuccinate) 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin (as erythromycin ethylsuccinate) 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Cefalexin 25 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Cefalexin 25 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Benorilate 400 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Benorilate 400 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely clarithromycin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely clarithromycin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Ferric ammonium citrate 16 mg/mL and folic acid 500 microgram/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| Ferric ammonium citrate 16 mg/mL and folic acid 500 microgram/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Ferric ammonium citrate 16 mg/mL and folic acid 100 microgram/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Ferric ammonium citrate 16 mg/mL and folic acid 100 microgram/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| Diazepam 1 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Diazepam 1 mg/mL oral solution |
har täljarvärde för koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Diazepam 1 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Naproxen 25 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydroxyzine hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely hydroxyzine hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Isoniazid 10 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Ethosuximide 50 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Ethosuximide 50 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Loratadine 1 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Loratadine 1 mg/mL oral solution |
har täljarvärde för koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Loratadine 1 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Cimetidine 40 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Cimetidine 40 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely atenolol 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely atenolol 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Orciprenaline sulfate 2 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Orciprenaline sulfate 2 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely magnesium hydroxide 83 milligram/1 milliliter conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely magnesium hydroxide 83 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 25 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 25 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely nitrazepam 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely nitrazepam 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Flucloxacillin (as flucloxacillin sodium) 25 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Flucloxacillin (as flucloxacillin sodium) 25 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely oxybutynin hydrochloride 500 microgram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely oxybutynin hydrochloride 500 microgram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely lithium citrate 104 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely lithium citrate 104 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Lofepramine (as lofepramine hydrochloride) 14 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Lofepramine (as lofepramine hydrochloride) 14 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely diazepam 500 microgram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Diazepam 2 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| amoxicillin (som amoxicillintrihydrat) 50 milligram/milliliter och klavulansyra (som kaliumklavulanat) 12,5 milligram/milliliter, oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| amoxicillin (som amoxicillintrihydrat) 50 milligram/milliliter och klavulansyra (som kaliumklavulanat) 12,5 milligram/milliliter, oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| Diphenhydramine hydrochloride 2 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Diphenhydramine hydrochloride 2 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely methadone hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |